CORMEDIX INC. - COMMON STOCK

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 май 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

19 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

15 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

11 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

08 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

27 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

06 мар 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Reimbursement Updates

30 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Operational Updates

08 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Appointment of Chief Legal Officer

15 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Partnership With The Leapfrog Group

04 дек 2023 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

15 ноя 2023 12:57:47 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

14 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023

02 ноя 2023 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference

11 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire